| Volume | 333,131 |
| Open | 1.560 |
| Bid (Size) | 1.510 (10,400) |
| Ask (Size) | 1.520 (6,600) |
| Prev. Close | 1.530 |
| Today's Range | 1.485 - 1.580 |
| 52wk Range | 1.400 - 2.610 |
| Shares Outstanding | 31,056,238 |
| Dividend Yield | N/A |
Inhibikase Therapeutics, Inc. - Common Stock (IKT) traded between $1.40 and $2.61 over the past 52 weeks and last traded at $1.52, 41.8% below its 52-week high. Over the past week it ranged between $1.49 and $1.73.
IKT was -5.6% over six months, -22.1% year to date, -9.5% in the last week.
Over the past 12 months IKT returned N/A versus DIA (Dow) +12.2%, SPY (S&P 500) +13.3%, QQQ (Nasdaq 100) +12.6% and IWM (Russell 2000) +19.2%.
IKT most recently traded 333,131 shares against a 3-month average daily volume of 571.1K.